Mary Ellen Usarzewicz
About Mary Ellen Usarzewicz
Mary Ellen Usarzewicz is the Director of QC Microbiology CAR T at Bristol Myers Squibb in Summit, New Jersey, with over 20 years of experience in microbiology and a strong background in quality control for CAR T cell therapy.
Title
Mary Ellen Usarzewicz is the Director of QC Microbiology CAR T at Bristol Myers Squibb, based in Summit, New Jersey, United States.
Current Role at Bristol Myers Squibb
Mary Ellen Usarzewicz holds the position of Director, QC Microbiology CAR T at Bristol Myers Squibb. Her role involves overseeing quality control microbiology processes specific to CAR T cell therapy, ensuring the highest standards of microbiological testing and compliance.
Past Roles at Bristol Myers Squibb
Mary Ellen Usarzewicz has held multiple roles at Bristol Myers Squibb. She served as Associate Director, Microbiology Analytical Strategy & Operations from 2018 to 2021, Group Leader from 2016 to 2018, Senior Research Scientist II from 2014 to 2016, Senior Research Scientist I from 2011 to 2014, Research Scientist II from 2010 to 2011, and Research Scientist I from 2007 to 2010. These positions were based in New Brunswick, NJ, and involved her in various capacities of microbiological research, quality control, and strategy.
Previous Experience
Before joining Bristol Myers Squibb, Mary Ellen Usarzewicz worked at Celsis as Associate Director, Microbiology from 2003 to 2007. Here, she gained significant experience in microbiological testing and quality control. Prior to that, she started her career at Gibraltar Laboratories as a Microbiologist from 2000 to 2003.
Education and Expertise
Mary Ellen Usarzewicz holds a Master of Science (MS) degree in Microbiology and a Bachelor of Science (BS) degree in Biology/Chemistry, both from Wagner College. Her strong educational background in both biology and chemistry has been pivotal in her extensive career in microbiology, spanning over 20 years.